1-8 of 8
Hun Mo Ryoo, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Multicenter Phase II Study Of Continuous Infusion Of FLAG For Patients Older Than 60 Years With Resistant Acute Myeloid Leukemia: A Comparison With Intensive Younger patients’ Trial

Hawk Kim, M.D., Je-Hwan Lee, M.D., Young-Don Joo, M.D., Sung-Hwa Bae, M.D., Ph.D., Jung-Hee Lee, Dae-Young Kim, M.D., Jae-Cheol Jo, Jae Hoo Park, Won Sik Lee, M.D., Hun-Mo Ryoo, MD, PhD, Sang-Kyu Park, Kyoo-Hyung Lee
Journal: Blood
Blood (2013) 122 (21): 3968.
https://doi.org/10.1182/blood.V122.21.3968.3968
Published: 2013
Journal Articles

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

Hawk Kim, Je-Hwan Lee, M.D., Young Don Joo, M.D., Sung Hwa Bae, MD, Jung-Hee Lee, M.D., Dae-Young Kim, M.D., Won-Sik Lee, MD, Hun-Mo Ryoo, MD, PhD, Jung Lim Lee, Jae Hoo Park, Kyoo Hyung Lee, M.D.
Journal: Blood
Blood (2011) 118 (21): 4952.
https://doi.org/10.1182/blood.V118.21.4952.4952
Published: 2011
Journal Articles

Trough Plasma Imatinib Levels and ABCG2 Polymorphisms Are Correlated with Optimal Cytogenetic Responses at 6 Months After Treatment with Standard Dose of Imatinib In Newly Diagnosed CML

Joon Ho Moon, MD, Sang Kyun Sohn, Soo Jung Lee, Yoo Jin Lee, Young Rok Do, Hyeoung Joon Kim, MD, PhD, Yeo Kyeoung Kim, Young Don Joo, Chul Won Jung, Dong Hwan Kim, Myung Soo Hyun, Min Kyoung Kim, Jooseop Chung, MD, PhD, Seonyang Park, Inho Kim, Joon Seong Park, Hawk Kim, MD, PhD, Jinny Park, Yoo-Hong Min, June-Won Cheong, MD, PhD, Hun-Mo Ryoo, MD, PhD, Ki-Seong Eom, Eun Kyung Park, Moo Rim Park, Suk-Joong Oh, Byung Soo Kim, Chul Soo Kim, Dae Young Zang, Soo-Mee Bang, Hong Ghi Lee, Deog Yeon Jo, Jong Ho Won
Journal: Blood
Blood (2010) 116 (21): 2272.
https://doi.org/10.1182/blood.V116.21.2272.2272
Published: 2010
Journal Articles

Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome

Hawk Kim, Jae-Hoo Park, Je-Hwan Lee, Young Don Joo, Won-Sik Lee, Sung-Hwa Bae, MD, Hun-Mo Ryoo, MD, PhD, Myung Soo Hyun, Min Kyung Kim, Dae Young Zang, Hyo Jung Kim, Kyoo Hyung Lee
Journal: Blood
Blood (2010) 116 (21): 34.
https://doi.org/10.1182/blood.V116.21.34.34
Published: 2010
Journal Articles

Intensified 1st Cycle Rituximab (R) Plus 8 th Cycles of R-CHOP (cyclophosphamide, adriamycin, vincristine, prednisolone) Chemotherapy In Patients with Advanced or Bulky CD20 + Diffuse Large B-Cell Lymphoma (DLBCL); Open-Labelled, Multicenter Phase II CISL Study-Interim Analysis.

Jin Seok Kim, Won Seog Kim, Seok Jin Kim, MD, PhD, Hyeon Seok Eom, Deok-Hwan Yang, Yang Soo Kim, Hyo Jung Kim, Min Kyoung Kim, Suk-Joong Oh, Sung-Soo Yoon, Hun-Mo Ryoo, MD, PhD, Jae-Yong Kwak, Jae Hoon Lee, MD, PhD, Chul Won Choi, Hye Jin Kang, Yeung-Chul Mun, yun Deok Kim, Cheolwon Suh, MD
Journal: Blood
Blood (2010) 116 (21): 1786.
https://doi.org/10.1182/blood.V116.21.1786.1786
Published: 2010
Journal Articles

VEGFA and VEGFR2 Genetic Polymorphisms and Survival In Patients with Diffuse Large B Cell Lymphoma

Min Kyoung Kim, Cheolwon Suh, MD, Hyun Sook Chi, Hee Soon Cho, Kyung Hee Lee, Gyeong-Won Lee, In-Suk Kim, MD, PhD, Hyeon Seok Eom, Sun-Young Kong, MD, PhD, Sung Hwa Bae, Hun-Mo Ryoo, MD, PhD, Yeung-Chul Mun, MD, PhD, Hwasoon Chung, Myung Soo Hyun
Journal: Blood
Blood (2010) 116 (21): 994.
https://doi.org/10.1182/blood.V116.21.994.994
Published: 2010
Journal Articles

The Predictive Role of Germinal Center or Non-Germinal Center Phenotypes in Diffuse Large B-Cell Lymphoma Patients Receiving CHOP or R-CHOP

Sun-ah Lee, MD, Hun-Mo Ryoo, MD, PhD, Sung Hwa Bae, MD, Hyun Young Jung, MD, Saet Byul Jang, MD, Yoon Seop Keum, MD
Journal: Blood
Blood (2008) 112 (11): 5290.
https://doi.org/10.1182/blood.V112.11.5290.5290
Published: 2008
Journal Articles

Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.

Hawk Kim, MD, PhD, Jae-Hoo Park, MD, PhD, Je-Hwan Lee, MD, PhD, Jung-Hee Lee, MD, PhD, Young-Don Joo, MD, PhD, Won-Sik Lee, MD, PhD, Sung-Hwa Bae, MD, PhD, Hun Mo Ryoo, MD, PhD, Kyoo-Hyung Lee, MD, PhD, Cooperative Study Group A for Hematology
Journal: Blood
Blood (2007) 110 (11): 4350.
https://doi.org/10.1182/blood.V110.11.4350.4350
Published: 2007